Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: insulin lispro protamine recombinant; insulin lispro recombinant

« Back to Dashboard
Insulin lispro protamine recombinant; insulin lispro recombinant is the generic ingredient in six branded drugs marketed by Lilly and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has eleven patent family members in nine countries.

There are thirty-eight drug master file entries for insulin lispro protamine recombinant; insulin lispro recombinant. Two suppliers are listed for this compound.

Summary for Generic Name: insulin lispro protamine recombinant; insulin lispro recombinant

Tradenames:6
Patents:1
Applicants:1
NDAs:2
Drug Master File Entries: see list38
Suppliers / Packaging: see list9

Pharmacology for Ingredient: insulin lispro protamine recombinant; insulin lispro recombinant

Ingredient-typeInsulin
Drug ClassInsulin Analog

Clinical Trials for: insulin lispro protamine recombinant; insulin lispro recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
HUMALOG MIX 75/25 PEN
insulin lispro protamine recombinant; insulin lispro recombinant
INJECTABLE;INJECTION021017-003Dec 22, 1999DISCNNo<disabled><disabled>
Lilly
HUMALOG MIX 50/50
insulin lispro protamine recombinant; insulin lispro recombinant
INJECTABLE;INJECTION021018-001Dec 22, 1999RXYes<disabled><disabled>
Lilly
HUMALOG MIX 50/50 PEN
insulin lispro protamine recombinant; insulin lispro recombinant
INJECTABLE;INJECTION021018-003Dec 22, 1999DISCNNo<disabled><disabled>
Lilly
HUMALOG MIX 75/25 KWIKPEN
insulin lispro protamine recombinant; insulin lispro recombinant
INJECTABLE;INJECTION021017-002Sep 6, 2007RXYes7,291,132<disabled>Y<disabled>
Lilly
HUMALOG MIX 75/25
insulin lispro protamine recombinant; insulin lispro recombinant
INJECTABLE;INJECTION021017-001Dec 22, 1999RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: insulin lispro protamine recombinant; insulin lispro recombinant

Country Document Number Publication Date
World Intellectual Property Organization (WIPO)2005018721Mar 03, 2005
Canada2530263Mar 03, 2005
Norway20061150May 04, 2006
Australia2004266131Mar 03, 2005
China1835774Sep 20, 2006
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc